{"gene":"LTB","run_date":"2026-04-28T18:30:27","timeline":{"discoveries":[{"year":1993,"finding":"LTB (lymphotoxin beta) was identified as a novel type II transmembrane protein of the TNF superfamily that forms a heteromeric complex with LTα (lymphotoxin alpha) on the cell surface of activated T, B, and LAK cells. The LTα/LTβ complex is anchored to the membrane via LTβ, and the LTB gene was found adjacent to the TNF-LTα locus within the MHC.","method":"cDNA cloning, immunoprecipitation, surface immunofluorescence, Northern blot, chromosomal mapping","journal":"Cell","confidence":"High","confidence_rationale":"Tier 1–2 — original discovery paper with cDNA cloning, co-IP/immunoprecipitation demonstrating complex formation, and multiple orthogonal characterization methods; foundational paper with 444 citations","pmids":["7916655"],"is_preprint":false},{"year":1991,"finding":"Surface lymphotoxin on activated T cell hybridoma II-23.D7 exists as a complex between LTα (p25) and an associated 33 kDa glycoprotein (later identified as LTβ). Peptide mapping showed p33 is biochemically distinct from LTα, and biosynthetic labeling showed p33 contains cysteine whereas p25/LTα does not, indicating p33 anchors LTα to the cell surface.","method":"Surface radioiodination, immunoprecipitation with anti-LT antibodies, CNBr peptide mapping, biosynthetic labeling, glycanase digestion","journal":"Journal of immunology","confidence":"High","confidence_rationale":"Tier 1–2 — multiple biochemical methods (immunoprecipitation, peptide mapping, biosynthetic labeling) establishing the identity and membrane-anchoring role of LTβ; 80 citations","pmids":["1714477"],"is_preprint":false},{"year":1995,"finding":"Two distinct surface LT complexes were characterized on PMA-activated T cells: a minor LTα2/β1 form recognized by the p55-TNF receptor, and a predominant LTα1/β2 form that is the primary ligand for the LTβ receptor. Neither heteromeric form is secreted. The LTα1/β2 stoichiometry was confirmed using panels of anti-LTα and anti-LTβ monoclonal antibodies and soluble receptor-Ig fusion proteins.","method":"FACS with monoclonal antibodies, soluble receptor-Ig binding assays, immunoprecipitation, flow cytometry","journal":"Journal of immunology","confidence":"High","confidence_rationale":"Tier 2 — reciprocal antibody characterization and soluble receptor binding with multiple mAbs establishing stoichiometry of LTα/LTβ surface complexes; replicated across multiple cell lines; 138 citations","pmids":["7995952"],"is_preprint":false},{"year":1997,"finding":"In mouse lymphocytes, CD4+ T cells, CD8+ T cells, and B cells express surface LTα/LTβ complexes upon activation, while monocytes/macrophages express LTβ receptor but not surface LT ligand. Murine surface LT complex properties parallel those in humans, establishing conserved expression patterns across species.","method":"FACS analysis with anti-murine LTα, LTβ monoclonal antibodies and soluble LTβR-Ig and TNF-R55-Ig fusion proteins on primary splenocytes, thymocytes, lymph node and peritoneal cells","journal":"Journal of immunology","confidence":"High","confidence_rationale":"Tier 2 — systematic characterization of primary murine immune cell populations using reciprocal antibody and soluble receptor tools; 129 citations","pmids":["9317127"],"is_preprint":false},{"year":1998,"finding":"cAMP-mediated transcriptional repressor ICER attenuates lymphotoxin-beta gene expression in human thymocytes by binding to NFAT/AP-1 composite DNA sites in the LTβ promoter region, forming NFAT/ICER ternary complexes that repress transcription.","method":"EMSA (electrophoretic mobility shift assay), transient transfection with ICER expression constructs, luciferase reporter assays, Northern blot analysis of primary thymocytes","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 — EMSA and reporter assays establishing ICER binding to LTβ promoter elements and functional repression; single lab study","pmids":["9545284"],"is_preprint":false},{"year":2002,"finding":"Human immature dendritic cells express LTα1β2 on their cell surface as one of four TNF family cytotoxic ligands mediating direct apoptotic killing of tumor cells. Blocking LTα1β2 interactions with LTβR on tumor cells using specific antibodies or LTβR:Fc fusion proteins reduced DC-mediated tumor cell killing.","method":"Flow cytometry for surface expression, neutralizing antibodies and receptor:Fc fusion protein blockade, cytotoxicity assays with freshly isolated and cultured cancer cells","journal":"Journal of immunology","confidence":"Medium","confidence_rationale":"Tier 2 — functional blocking experiments with defined reagents establishing LTα1β2 as a mediator of DC cytotoxicity; single lab","pmids":["11823516"],"is_preprint":false},{"year":2008,"finding":"LTα1β2 (as well as LIGHT) activates both classical and noncanonical NF-κB pathways in vascular endothelial cells, inducing expression of adhesion molecules (E-selectin, ICAM-1, VCAM-1) via classical NF-κB and homeostatic chemokine CXCL12 via the noncanonical pathway. CXCL12 induction by LTβR ligation is dependent on IKKα (noncanonical pathway) as shown by dominant-negative IKKα retroviral transduction.","method":"NF-κB pathway activation assays, retroviral transduction with dominant-negative IKKα, qRT-PCR and Western blot for target genes, T cell adhesion assays in HUVEC and HDMEC","journal":"Journal of immunology","confidence":"High","confidence_rationale":"Tier 2 — mechanistic pathway dissection using dominant-negative constructs, multiple cell types, and multiple orthogonal readouts; 74 citations","pmids":["18292573"],"is_preprint":false},{"year":2009,"finding":"Hepatic overexpression of LTα and LTβ in transgenic mice induces liver inflammation and hepatocellular carcinoma (HCC). HCC development depends on lymphocytes and hepatocyte-expressed IKKβ (classical NF-κB signaling) but is independent of TNFR1. In vivo LTβR inhibition with LTβR:Ig fusion protein suppressed HCC formation in LTαβ-transgenic mice with hepatitis, establishing LTβR signaling as causally linked to hepatitis-induced HCC.","method":"Liver-specific LTαβ transgenic mouse model, LTβR:Ig blockade in vivo, IKKβ conditional knockout, TNFR1-deficient crosses, histopathology, A6+ oval cell staining","journal":"Cancer cell","confidence":"High","confidence_rationale":"Tier 2 — genetic epistasis via multiple knockout/transgenic crosses and in vivo receptor blockade establishing causal LTβ→LTβR→IKKβ pathway in HCC; 329 citations","pmids":["19800575"],"is_preprint":false},{"year":2014,"finding":"T lymphocyte-derived LTβ maintains the structure and function of fibroblastic reticular cells (FRCs) in the spleen. In nude mice lacking T cells, FRC structure was disrupted, ER-TR7 secretion was reduced, and CCL21/CCL19 expression was downregulated. Transfusion of T cells restored FRC structure and function, but this restoration was abrogated when LTβ receptor was blocked, identifying LTβ as the T cell-derived signal required for FRC homeostasis.","method":"Nude mouse model (T cell-deficient), T cell transfer experiments, LTβR blockade, immunohistochemistry for FRC markers, qRT-PCR for CCL19/CCL21, T cell homing assays","journal":"BMC immunology","confidence":"Medium","confidence_rationale":"Tier 2 — genetic loss-of-function (nude mice) combined with rescue (T cell transfer) and receptor blockade establishing LTβ as the functional signal; single lab","pmids":["25266629"],"is_preprint":false}],"current_model":"LTB encodes lymphotoxin beta (LTβ), a type II transmembrane TNF superfamily member that anchors LTα to the lymphocyte surface as predominant LTα1β2 heterotrimers (minor LTα2β1 also exists); this surface complex signals exclusively through the LTβ receptor (LTβR) to activate both classical (IKKβ-dependent) and noncanonical (IKKα-dependent) NF-κB pathways, driving lymphoid organogenesis, FRC homeostasis, endothelial activation (ICAM-1, VCAM-1, CXCL12 induction), DC-mediated tumor cytotoxicity, and—when chronically overexpressed in the liver—hepatocellular carcinoma via IKKβ in a TNFR1-independent manner."},"narrative":{"teleology":[{"year":1991,"claim":"The discovery that surface lymphotoxin exists as a complex of LTα with a biochemically distinct 33 kDa glycoprotein (later identified as LTβ) resolved how soluble LTα is retained at the cell membrane.","evidence":"Surface radioiodination, immunoprecipitation, CNBr peptide mapping, and biosynthetic labeling on activated T cell hybridoma II-23.D7","pmids":["1714477"],"confidence":"High","gaps":["Identity of p33 was not yet established at the molecular/cDNA level","Receptor specificity of the surface complex was unknown"]},{"year":1993,"claim":"Cloning of the LTB cDNA established LTβ as a type II transmembrane TNF family member encoded within the MHC locus, anchoring LTα to the cell surface of activated T, B, and LAK cells.","evidence":"cDNA cloning, co-immunoprecipitation, surface immunofluorescence, Northern blot, and chromosomal mapping","pmids":["7916655"],"confidence":"High","gaps":["Stoichiometry of the LTα/LTβ complex was not defined","Which receptor the surface complex engages was unresolved"]},{"year":1995,"claim":"Defining the stoichiometry of the two surface LT heterotrimers—predominant LTα1β2 and minor LTα2β1—and showing LTα1β2 is the primary LTβR ligand resolved the ligand–receptor specificity question.","evidence":"FACS with panels of anti-LTα and anti-LTβ monoclonal antibodies, soluble TNF-R55-Ig and LTβR-Ig binding assays across multiple cell lines","pmids":["7995952"],"confidence":"High","gaps":["Downstream signaling pathways triggered by LTβR were not yet dissected","In vivo physiological role of the LTα1β2–LTβR axis was undemonstrated"]},{"year":1997,"claim":"Demonstration that murine CD4+ T, CD8+ T, and B cells express surface LTα/LTβ upon activation—paralleling the human system—established evolutionary conservation and validated the mouse as a model for LTβ biology.","evidence":"FACS analysis of primary murine splenocytes, thymocytes, lymph node and peritoneal cells with anti-murine LTα/LTβ mAbs and soluble receptor-Ig fusions","pmids":["9317127"],"confidence":"High","gaps":["Functional consequences of LTβR engagement in vivo (e.g., lymphoid organogenesis) were being established by parallel genetic studies not captured here"]},{"year":1998,"claim":"Identification of ICER-mediated repression of LTβ transcription via NFAT/AP-1 composite elements revealed a cAMP-dependent brake on LTβ expression in thymocytes.","evidence":"EMSA, transient transfection with ICER constructs, luciferase reporter assays, and Northern blot in human thymocytes","pmids":["9545284"],"confidence":"Medium","gaps":["Physiological relevance of ICER repression in peripheral lymphocytes was not tested","Other transcription factors regulating LTβ expression were not identified"]},{"year":2002,"claim":"Showing that immature dendritic cells use surface LTα1β2–LTβR interactions to kill tumor cells expanded LTβ's functional repertoire beyond lymphoid organogenesis to innate anti-tumor cytotoxicity.","evidence":"Flow cytometry for surface LTα1β2, neutralizing antibodies/LTβR:Fc blockade, and cytotoxicity assays against freshly isolated cancer cells","pmids":["11823516"],"confidence":"Medium","gaps":["Whether DC-expressed LTα1β2 is relevant for tumor control in vivo was not established","The apoptotic pathway downstream of LTβR in tumor cells was not dissected"]},{"year":2008,"claim":"Dissection of dual NF-κB pathway activation downstream of LTβR in endothelial cells—classical NF-κB inducing adhesion molecules and noncanonical IKKα-dependent pathway inducing CXCL12—provided a mechanistic framework for LTβ-driven vascular inflammation and immune cell recruitment.","evidence":"Dominant-negative IKKα retroviral transduction, qRT-PCR, Western blot, and T cell adhesion assays in HUVEC and HDMEC","pmids":["18292573"],"confidence":"High","gaps":["Relative contribution of each NF-κB branch in different tissue contexts was not compared","Whether endothelial CXCL12 induction occurs in vivo during chronic inflammation was not shown"]},{"year":2009,"claim":"Genetic epistasis in hepatic LTαβ transgenic mice demonstrated that chronic LTβR signaling drives hepatocellular carcinoma via IKKβ (classical NF-κB) independent of TNFR1, establishing LTβR as a causal oncogenic pathway in inflammation-associated liver cancer.","evidence":"Liver-specific LTαβ transgenic mice, LTβR:Ig blockade in vivo, conditional IKKβ knockout, TNFR1-deficient crosses, histopathology","pmids":["19800575"],"confidence":"High","gaps":["Whether human hepatitis-associated HCC is similarly driven by LTβR signaling was not confirmed","Downstream IKKβ target genes responsible for hepatocyte transformation were not identified"]},{"year":2014,"claim":"T cell transfer and LTβR blockade experiments in nude mice identified LTβ as the T cell-derived signal required for maintaining fibroblastic reticular cell structure and chemokine (CCL19/CCL21) production in the spleen, linking LTβ to stromal homeostasis.","evidence":"Nude mouse model, T cell adoptive transfer, LTβR blockade, immunohistochemistry for FRC markers, qRT-PCR","pmids":["25266629"],"confidence":"Medium","gaps":["Whether LTβ acts directly on FRCs or through an intermediate cell type was not resolved","FRC maintenance in lymph nodes versus spleen may differ"]},{"year":null,"claim":"Outstanding questions include the structural basis of LTα1β2–LTβR engagement, the full transcriptional program downstream of LTβR in different tissue-resident cell types, and whether therapeutic LTβR blockade can safely suppress inflammation-driven carcinogenesis without compromising lymphoid tissue integrity.","evidence":"","pmids":[],"confidence":"High","gaps":["No crystal structure of the LTα1β2–LTβR complex has been reported in the timeline","Comprehensive LTβR target gene programs across cell types remain unmapped","Therapeutic window for LTβR blockade in cancer versus immunodeficiency is undefined"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0048018","term_label":"receptor ligand activity","supporting_discovery_ids":[0,2,5,6]}],"localization":[{"term_id":"GO:0005886","term_label":"plasma membrane","supporting_discovery_ids":[0,1,2,3,5]}],"pathway":[{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[6,7]},{"term_id":"R-HSA-168256","term_label":"Immune System","supporting_discovery_ids":[3,5,8]},{"term_id":"R-HSA-1643685","term_label":"Disease","supporting_discovery_ids":[7]}],"complexes":["LTα1β2 heterotrimer","LTα2β1 heterotrimer"],"partners":["LTA","LTBR","TNFRSF1A"],"other_free_text":[]},"mechanistic_narrative":"Lymphotoxin-beta (LTβ) is a type II transmembrane TNF superfamily member that anchors lymphotoxin-alpha (LTα) to the lymphocyte surface, forming predominant LTα1β2 heterotrimers that signal exclusively through the LTβ receptor (LTβR) to activate both classical (IKKβ-dependent) and noncanonical (IKKα-dependent) NF-κB pathways [PMID:7916655, PMID:7995952, PMID:18292573]. Surface LTα1β2 is expressed on activated CD4+ T cells, CD8+ T cells, and B cells, as well as immature dendritic cells, where it mediates endothelial activation (ICAM-1, VCAM-1, CXCL12 induction), fibroblastic reticular cell homeostasis, DC-mediated tumor cytotoxicity, and lymphoid tissue organization [PMID:9317127, PMID:11823516, PMID:25266629]. Chronic hepatic overexpression of LTαβ drives inflammation-associated hepatocellular carcinoma through LTβR and IKKβ in a TNFR1-independent manner [PMID:19800575]."},"prefetch_data":{"uniprot":{"accession":"Q06643","full_name":"Lymphotoxin-beta","aliases":["Tumor necrosis factor C","TNF-C","Tumor necrosis factor ligand superfamily member 3"],"length_aa":244,"mass_kda":25.4,"function":"Cytokine that binds to LTBR/TNFRSF3 (PubMed:24248355). May play a specific role in immune response regulation. Provides the membrane anchor for the attachment of the heterotrimeric complex to the cell surface. Isoform 2 is probably non-functional","subcellular_location":"Membrane","url":"https://www.uniprot.org/uniprotkb/Q06643/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/LTB","classification":"Not Classified","n_dependent_lines":0,"n_total_lines":1208,"dependency_fraction":0.0},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/LTB","total_profiled":1310},"omim":[{"mim_id":"610096","title":"T-CELL IMMUNOGLOBULIN AND MUCIN DOMAINS-CONTAINING PROTEIN 4; TIMD4","url":"https://www.omim.org/entry/610096"},{"mim_id":"607358","title":"AUTOIMMUNE REGULATOR; AIRE","url":"https://www.omim.org/entry/607358"},{"mim_id":"604655","title":"MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE 14; MAP3K14","url":"https://www.omim.org/entry/604655"},{"mim_id":"604520","title":"TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY, MEMBER 14; TNFSF14","url":"https://www.omim.org/entry/604520"},{"mim_id":"600979","title":"LYMPHOTOXIN B RECEPTOR; LTBR","url":"https://www.omim.org/entry/600979"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Approved","locations":[{"location":"Centrosome","reliability":"Approved"}],"tissue_specificity":"Group enriched","tissue_distribution":"Detected in many","driving_tissues":[{"tissue":"intestine","ntpm":61.7},{"tissue":"lymphoid tissue","ntpm":220.1}],"url":"https://www.proteinatlas.org/search/LTB"},"hgnc":{"alias_symbol":["p33","TNFSF3"],"prev_symbol":["TNFC"]},"alphafold":{"accession":"Q06643","domains":[{"cath_id":"2.60.120.40","chopping":"88-241","consensus_level":"high","plddt":89.6747,"start":88,"end":241}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q06643","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q06643-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q06643-F1-predicted_aligned_error_v6.png","plddt_mean":77.19},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=LTB","jax_strain_url":"https://www.jax.org/strain/search?query=LTB"},"sequence":{"accession":"Q06643","fasta_url":"https://rest.uniprot.org/uniprotkb/Q06643.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q06643/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q06643"}},"corpus_meta":[{"pmid":"16284309","id":"PMC_16284309","title":"Localization of the tomato bushy stunt virus replication protein p33 reveals a peroxisome-to-endoplasmic reticulum sorting pathway.","date":"2005","source":"The Plant cell","url":"https://pubmed.ncbi.nlm.nih.gov/16284309","citation_count":218,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"11784859","id":"PMC_11784859","title":"Role of the Sin3-histone deacetylase complex in growth regulation by the candidate tumor suppressor p33(ING1).","date":"2002","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/11784859","citation_count":191,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"15795271","id":"PMC_15795271","title":"Specific binding of tombusvirus replication protein p33 to an internal replication element in the viral RNA is essential for replication.","date":"2005","source":"Journal of virology","url":"https://pubmed.ncbi.nlm.nih.gov/15795271","citation_count":157,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"11414365","id":"PMC_11414365","title":"gC1q-R/p33, a member of a new class of multifunctional and multicompartmental cellular proteins, is involved in inflammation and infection.","date":"2001","source":"Immunological reviews","url":"https://pubmed.ncbi.nlm.nih.gov/11414365","citation_count":150,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"10722602","id":"PMC_10722602","title":"Staphylococcus aureus protein A recognizes platelet gC1qR/p33: a novel mechanism for staphylococcal interactions with platelets.","date":"2000","source":"Infection and immunity","url":"https://pubmed.ncbi.nlm.nih.gov/10722602","citation_count":142,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"10805724","id":"PMC_10805724","title":"Three yeast proteins related to the human candidate tumor suppressor p33(ING1) are associated with histone acetyltransferase activities.","date":"2000","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/10805724","citation_count":140,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"15159063","id":"PMC_15159063","title":"cC1q-R (calreticulin) and gC1q-R/p33: ubiquitously expressed multi-ligand binding cellular proteins involved in inflammation and infection.","date":"2004","source":"Molecular immunology","url":"https://pubmed.ncbi.nlm.nih.gov/15159063","citation_count":124,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"19131084","id":"PMC_19131084","title":"Translation elongation factor 1A is a component of the tombusvirus replicase complex and affects the stability of the p33 replication co-factor.","date":"2009","source":"Virology","url":"https://pubmed.ncbi.nlm.nih.gov/19131084","citation_count":111,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"11431327","id":"PMC_11431327","title":"The tumor suppressor candidate p33(ING1) mediates repair of UV-damaged DNA.","date":"2001","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/11431327","citation_count":99,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"9621045","id":"PMC_9621045","title":"Uncoupled expression of p33 and p92 permits amplification of tomato bushy stunt virus RNAs.","date":"1998","source":"Journal of virology","url":"https://pubmed.ncbi.nlm.nih.gov/9621045","citation_count":88,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"29042026","id":"PMC_29042026","title":"Identification, signaling, and functions of LTB4 receptors.","date":"2017","source":"Seminars in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/29042026","citation_count":79,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"15146564","id":"PMC_15146564","title":"Receptor for the globular heads of C1q (gC1q-R, p33, hyaluronan-binding protein) is preferentially expressed by adenocarcinoma cells.","date":"2004","source":"International journal of cancer","url":"https://pubmed.ncbi.nlm.nih.gov/15146564","citation_count":77,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"11257419","id":"PMC_11257419","title":"Oral immunisation of naive and primed animals with transgenic potato tubers expressing LT-B.","date":"2001","source":"Vaccine","url":"https://pubmed.ncbi.nlm.nih.gov/11257419","citation_count":73,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"12706102","id":"PMC_12706102","title":"The overlapping RNA-binding domains of p33 and p92 replicase proteins are essential for tombusvirus replication.","date":"2003","source":"Virology","url":"https://pubmed.ncbi.nlm.nih.gov/12706102","citation_count":70,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"18388957","id":"PMC_18388957","title":"NAD(P)H quinone oxidoreductase 1 inhibits the proteasomal degradation of the tumour suppressor p33(ING1b).","date":"2008","source":"EMBO reports","url":"https://pubmed.ncbi.nlm.nih.gov/18388957","citation_count":68,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"31744753","id":"PMC_31744753","title":"The C1q Receptors: Focus on gC1qR/p33 (C1qBP, p32, HABP-1)1.","date":"2019","source":"Seminars in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/31744753","citation_count":67,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"17544818","id":"PMC_17544818","title":"The contribution of gC1qR/p33 in infection and inflammation.","date":"2007","source":"Immunobiology","url":"https://pubmed.ncbi.nlm.nih.gov/17544818","citation_count":65,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"15817461","id":"PMC_15817461","title":"Functional properties of the p33 and p55 domains of the Helicobacter pylori vacuolating cytotoxin.","date":"2005","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/15817461","citation_count":61,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"11600420","id":"PMC_11600420","title":"Effects of IL-8, Gro-alpha, and LTB(4) on the adhesive kinetics of LFA-1 and Mac-1 on human neutrophils.","date":"2001","source":"American journal of physiology. Cell physiology","url":"https://pubmed.ncbi.nlm.nih.gov/11600420","citation_count":60,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"11003605","id":"PMC_11003605","title":"15(S)-HETE modulates LTB(4) production and neutrophil chemotaxis in chronic bronchitis.","date":"2000","source":"American journal of physiology. Cell physiology","url":"https://pubmed.ncbi.nlm.nih.gov/11003605","citation_count":59,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"15451426","id":"PMC_15451426","title":"Identification of a novel BRMS1-homologue protein p40 as a component of the mSin3A/p33(ING1b)/HDAC1 deacetylase complex.","date":"2004","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/15451426","citation_count":59,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"6412232","id":"PMC_6412232","title":"Isolation of cDNA clones for the p33 invariant chain associated with HLA-DR antigens.","date":"1983","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/6412232","citation_count":58,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"20861245","id":"PMC_20861245","title":"Autographa californica multiple nucleopolyhedrovirus Ac92 (ORF92, P33) is required for budded virus production and multiply enveloped occlusion-derived virus formation.","date":"2010","source":"Journal of virology","url":"https://pubmed.ncbi.nlm.nih.gov/20861245","citation_count":57,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"25044096","id":"PMC_25044096","title":"cC1qR/CR and gC1qR/p33: observations in cancer.","date":"2014","source":"Molecular immunology","url":"https://pubmed.ncbi.nlm.nih.gov/25044096","citation_count":52,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"15234555","id":"PMC_15234555","title":"Expression of gC1q-R/p33 and its major ligands in human atherosclerotic lesions.","date":"2004","source":"Molecular immunology","url":"https://pubmed.ncbi.nlm.nih.gov/15234555","citation_count":52,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"12396004","id":"PMC_12396004","title":"gC1q-R/p33: structure-function predictions from the crystal structure.","date":"2002","source":"Immunobiology","url":"https://pubmed.ncbi.nlm.nih.gov/12396004","citation_count":48,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"10807544","id":"PMC_10807544","title":"p24/ING1-ALT1 and p47/ING1-ALT2, distinct alternative transcripts of p33/ING1.","date":"2000","source":"Journal of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/10807544","citation_count":48,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"8985157","id":"PMC_8985157","title":"Kininogen binding protein p33/gC1qR is localized in the vesicular fraction of endothelial cells.","date":"1996","source":"FEBS letters","url":"https://pubmed.ncbi.nlm.nih.gov/8985157","citation_count":48,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"12574814","id":"PMC_12574814","title":"Activation-dependent surface expression of gC1qR/p33 on human blood platelets.","date":"2003","source":"Thrombosis and haemostasis","url":"https://pubmed.ncbi.nlm.nih.gov/12574814","citation_count":47,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"14593124","id":"PMC_14593124","title":"Interactions between p-33 and p-55 domains of the Helicobacter pylori vacuolating cytotoxin (VacA).","date":"2003","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/14593124","citation_count":46,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"19958557","id":"PMC_19958557","title":"Recombinant porcine rotavirus VP4 and VP4-LTB expressed in Lactobacillus casei induced mucosal and systemic antibody responses in mice.","date":"2009","source":"BMC microbiology","url":"https://pubmed.ncbi.nlm.nih.gov/19958557","citation_count":45,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"12835293","id":"PMC_12835293","title":"The role of the tumour suppressor p33 ING1b in human neoplasia.","date":"2003","source":"Journal of clinical pathology","url":"https://pubmed.ncbi.nlm.nih.gov/12835293","citation_count":44,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"11076655","id":"PMC_11076655","title":"Expression of the novel tumour suppressor p33(ING1)is independent of p53.","date":"2000","source":"British journal of cancer","url":"https://pubmed.ncbi.nlm.nih.gov/11076655","citation_count":44,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"16242746","id":"PMC_16242746","title":"Kinetics and functional studies on interaction between the replicase proteins of Tomato Bushy Stunt Virus: requirement of p33:p92 interaction for replicase assembly.","date":"2005","source":"Virology","url":"https://pubmed.ncbi.nlm.nih.gov/16242746","citation_count":44,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"16856209","id":"PMC_16856209","title":"Neutrophil recruitment in immunized mice depends on MIP-2 inducing the sequential release of MIP-1alpha, TNF-alpha and LTB(4).","date":"2006","source":"European journal of immunology","url":"https://pubmed.ncbi.nlm.nih.gov/16856209","citation_count":43,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"24606690","id":"PMC_24606690","title":"The p33 auxiliary replicase protein of Cucumber necrosis virus targets peroxisomes and infection induces de novo peroxisome formation from the endoplasmic reticulum.","date":"2014","source":"Virology","url":"https://pubmed.ncbi.nlm.nih.gov/24606690","citation_count":43,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"20615415","id":"PMC_20615415","title":"Both the p33 and p55 subunits of the Helicobacter pylori VacA toxin are targeted to mammalian mitochondria.","date":"2010","source":"Journal of molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/20615415","citation_count":43,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"30220089","id":"PMC_30220089","title":"The p33 protein of Citrus tristeza virus affects viral pathogenicity by modulating a host immune response.","date":"2018","source":"The New phytologist","url":"https://pubmed.ncbi.nlm.nih.gov/30220089","citation_count":42,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"11956069","id":"PMC_11956069","title":"Identification of the p33(ING1)-regulated genes that include cyclin B1 and proto-oncogene DEK by using cDNA microarray in a mouse mammary epithelial cell line NMuMG.","date":"2002","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/11956069","citation_count":42,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"29042029","id":"PMC_29042029","title":"LTB4 and BLT1 in inflammatory arthritis.","date":"2017","source":"Seminars in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/29042029","citation_count":41,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"17585055","id":"PMC_17585055","title":"Phosphorylation of the tumor suppressor p33(ING1b) at Ser-126 influences its protein stability and proliferation of melanoma cells.","date":"2007","source":"FASEB journal : official publication of the Federation of American Societies for Experimental Biology","url":"https://pubmed.ncbi.nlm.nih.gov/17585055","citation_count":41,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"11850840","id":"PMC_11850840","title":"Facilitation of adenoviral wild-type p53-induced apoptotic cell death by overexpression of p33(ING1) in T.Tn human esophageal carcinoma cells.","date":"2002","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/11850840","citation_count":41,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"16893067","id":"PMC_16893067","title":"gC1qR/p33 serves as a molecular bridge between the complement and contact activation systems and is an important catalyst in inflammation.","date":"2006","source":"Advances in experimental medicine and biology","url":"https://pubmed.ncbi.nlm.nih.gov/16893067","citation_count":39,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"27860074","id":"PMC_27860074","title":"Immunogenicity of recombinant Lactobacillus casei-expressing F4 (K88) fimbrial adhesin FaeG in conjunction with a heat-labile enterotoxin A (LTAK63) and heat-labile enterotoxin B (LTB) of enterotoxigenic Escherichia coli as an oral adjuvant in mice.","date":"2016","source":"Journal of applied microbiology","url":"https://pubmed.ncbi.nlm.nih.gov/27860074","citation_count":39,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"21447051","id":"PMC_21447051","title":"Plastid expression of a double-pentameric vaccine candidate containing human papillomavirus-16 L1 antigen fused with LTB as adjuvant: transplastomic plants show pleiotropic phenotypes.","date":"2011","source":"Plant biotechnology journal","url":"https://pubmed.ncbi.nlm.nih.gov/21447051","citation_count":39,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"8719215","id":"PMC_8719215","title":"A genetic hybrid of the Campylobacter jejuni flaA gene with LT-B of Escherichia coli and assessment of the efficacy of the hybrid protein as an oral chicken vaccine.","date":"1995","source":"Avian diseases","url":"https://pubmed.ncbi.nlm.nih.gov/8719215","citation_count":37,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"19586628","id":"PMC_19586628","title":"Participation of 5-lipoxygenase-derived LTB(4) in 4-hydroxynonenal-enhanced MMP-2 production in vascular smooth muscle cells.","date":"2009","source":"Atherosclerosis","url":"https://pubmed.ncbi.nlm.nih.gov/19586628","citation_count":37,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"12147653","id":"PMC_12147653","title":"Loss of nuclear expression of the p33(ING1b) inhibitor of growth protein in childhood acute lymphoblastic leukaemia.","date":"2002","source":"Journal of clinical pathology","url":"https://pubmed.ncbi.nlm.nih.gov/12147653","citation_count":36,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"11414364","id":"PMC_11414364","title":"Human blood platelet gC1qR/p33.","date":"2001","source":"Immunological reviews","url":"https://pubmed.ncbi.nlm.nih.gov/11414364","citation_count":34,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"12835295","id":"PMC_12835295","title":"Downregulation of nuclear expression of the p33(ING1b) inhibitor of growth protein in invasive carcinoma of the breast.","date":"2003","source":"Journal of clinical pathology","url":"https://pubmed.ncbi.nlm.nih.gov/12835295","citation_count":34,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"23675482","id":"PMC_23675482","title":"Mucosal and systemic immune responses to Mycobacterium tuberculosis antigen 85A following its co-delivery with CpG, MPLA or LTB to the lungs in mice.","date":"2013","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/23675482","citation_count":34,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"18475433","id":"PMC_18475433","title":"Cytokine gene regulation by PGE(2), LTB(4) and PAF.","date":"1992","source":"Mediators of inflammation","url":"https://pubmed.ncbi.nlm.nih.gov/18475433","citation_count":33,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"31666208","id":"PMC_31666208","title":"Eicosanoid pathway on host resistance and inflammation during Mycobacterium tuberculosis infection is comprised by LTB4 reduction but not PGE2 increment.","date":"2019","source":"Biochimica et biophysica acta. Molecular basis of disease","url":"https://pubmed.ncbi.nlm.nih.gov/31666208","citation_count":32,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"11688989","id":"PMC_11688989","title":"Identification of dual cyclooxygenase-eicosanoid oxidoreductase inhibitors: NSAIDs that inhibit PG-LX reductase/LTB(4) dehydrogenase.","date":"2001","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/11688989","citation_count":32,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"15618162","id":"PMC_15618162","title":"Construction and characterization of bivalent Shigella flexneri 2a vaccine strains SC608(pCFAI) and SC608(pCFAI/LTB) that express antigens from enterotoxigenic Escherichia coli.","date":"2005","source":"Infection and immunity","url":"https://pubmed.ncbi.nlm.nih.gov/15618162","citation_count":32,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"28965882","id":"PMC_28965882","title":"The inhibition of 5-Lipoxygenase (5-LO) products leukotriene B4 (LTB4) and cysteinyl leukotrienes (cysLTs) modulates the inflammatory response and improves cutaneous wound healing.","date":"2017","source":"Clinical immunology (Orlando, Fla.)","url":"https://pubmed.ncbi.nlm.nih.gov/28965882","citation_count":31,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"19409596","id":"PMC_19409596","title":"The conserved baculovirus protein p33 (Ac92) is a flavin adenine dinucleotide-linked sulfhydryl oxidase.","date":"2009","source":"Virology","url":"https://pubmed.ncbi.nlm.nih.gov/19409596","citation_count":30,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"29482166","id":"PMC_29482166","title":"The composition of accessory enzymes of Penicillium chrysogenum P33 revealed by secretome and synergistic effects with commercial cellulase on lignocellulose hydrolysis.","date":"2018","source":"Bioresource technology","url":"https://pubmed.ncbi.nlm.nih.gov/29482166","citation_count":30,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"33847026","id":"PMC_33847026","title":"Oral multivalent epitope vaccine, based on UreB, HpaA, CAT, and LTB, for prevention and treatment of Helicobacter pylori infection in C57BL / 6 mice.","date":"2021","source":"Helicobacter","url":"https://pubmed.ncbi.nlm.nih.gov/33847026","citation_count":29,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"25461533","id":"PMC_25461533","title":"Tombusviruses upregulate phospholipid biosynthesis via interaction between p33 replication protein and yeast lipid sensor proteins during virus replication in yeast.","date":"2014","source":"Virology","url":"https://pubmed.ncbi.nlm.nih.gov/25461533","citation_count":29,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"10085088","id":"PMC_10085088","title":"Characterization of the p33 subunit of eukaryotic translation initiation factor-3 from Saccharomyces cerevisiae.","date":"1999","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/10085088","citation_count":29,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"24909331","id":"PMC_24909331","title":"Immune responses of a chimaeric protein vaccine containing Mycoplasma hyopneumoniae antigens and LTB against experimental M. hyopneumoniae infection in pigs.","date":"2014","source":"Vaccine","url":"https://pubmed.ncbi.nlm.nih.gov/24909331","citation_count":29,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"25091529","id":"PMC_25091529","title":"Local and systemic immune responses induced by a recombinant chimeric protein containing Mycoplasma hyopneumoniae antigens fused to the B subunit of Escherichia coli heat-labile enterotoxin LTB.","date":"2014","source":"Veterinary microbiology","url":"https://pubmed.ncbi.nlm.nih.gov/25091529","citation_count":29,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"34417262","id":"PMC_34417262","title":"LTB4-Driven Inflammation and Increased Expression of ALOX5/ACE2 During Severe COVID-19 in Individuals With Diabetes.","date":"2021","source":"Diabetes","url":"https://pubmed.ncbi.nlm.nih.gov/34417262","citation_count":28,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"17310334","id":"PMC_17310334","title":"Expression of Escherichia coli heat-labile enterotoxin b subunit (LTB) in carrot (Daucus carota L.).","date":"2007","source":"Plant cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/17310334","citation_count":28,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"28950907","id":"PMC_28950907","title":"A novel bifunctional acetyl xylan esterase/arabinofuranosidase from Penicillium chrysogenum P33 enhances enzymatic hydrolysis of lignocellulose.","date":"2017","source":"Microbial cell factories","url":"https://pubmed.ncbi.nlm.nih.gov/28950907","citation_count":27,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"9882325","id":"PMC_9882325","title":"Baculovirus p33 binds human p53 and enhances p53-mediated apoptosis.","date":"1999","source":"Journal of virology","url":"https://pubmed.ncbi.nlm.nih.gov/9882325","citation_count":26,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"28303931","id":"PMC_28303931","title":"The development of novel LTA4H modulators to selectively target LTB4 generation.","date":"2017","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/28303931","citation_count":26,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"12121145","id":"PMC_12121145","title":"99mTc-Labeling of a hydrazinonicotinamide-conjugated LTB(4) receptor antagonist useful for imaging infection and inflammation.","date":"2002","source":"Bioconjugate chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/12121145","citation_count":26,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"30676680","id":"PMC_30676680","title":"20-Hydroxy- and 20-carboxy-leukotriene (LT) B4 downregulate LTB4 -mediated responses of human neutrophils and eosinophils.","date":"2019","source":"Journal of leukocyte biology","url":"https://pubmed.ncbi.nlm.nih.gov/30676680","citation_count":25,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"28811215","id":"PMC_28811215","title":"Molecular mechanisms underlying protection against H9N2 influenza virus challenge in mice by recombinant Lactobacillus plantarum with surface displayed HA2-LTB.","date":"2017","source":"Journal of biotechnology","url":"https://pubmed.ncbi.nlm.nih.gov/28811215","citation_count":25,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"10430706","id":"PMC_10430706","title":"LTB(4)-induced nasal gland serous cell secretion mediated by neutrophil elastase.","date":"1999","source":"American journal of respiratory and critical care medicine","url":"https://pubmed.ncbi.nlm.nih.gov/10430706","citation_count":24,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"20965540","id":"PMC_20965540","title":"Autographa californica multiple nucleopolyhedrovirus core gene ac92 (p33) is required for efficient budded virus production.","date":"2010","source":"Virology","url":"https://pubmed.ncbi.nlm.nih.gov/20965540","citation_count":23,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"22053005","id":"PMC_22053005","title":"Construction of Bifidobacterium infantis as a live oral vaccine that expresses antigens of the major fimbrial subunit (CfaB) and the B subunit of heat-labile enterotoxin (LTB) from enterotoxigenic Escherichia coli.","date":"2011","source":"Microbiology (Reading, England)","url":"https://pubmed.ncbi.nlm.nih.gov/22053005","citation_count":23,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"28827365","id":"PMC_28827365","title":"Capturing LTA4 hydrolase in action: Insights to the chemistry and dynamics of chemotactic LTB4 synthesis.","date":"2017","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/28827365","citation_count":22,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"15800978","id":"PMC_15800978","title":"Inhibitory effect of tumor suppressor p33(ING1b) and its synergy with p53 gene in hepatocellular carcinoma.","date":"2005","source":"World journal of gastroenterology","url":"https://pubmed.ncbi.nlm.nih.gov/15800978","citation_count":22,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"8150091","id":"PMC_8150091","title":"Highly polarized expression of carbohydrate-binding protein p33/41 (annexin IV) on the apical plasma membrane of epithelial cells in renal proximal tubules.","date":"1994","source":"FEBS letters","url":"https://pubmed.ncbi.nlm.nih.gov/8150091","citation_count":22,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"21085949","id":"PMC_21085949","title":"Protection of mice against enterotoxigenic E. coli by immunization with a polyvalent enterotoxin comprising a combination of LTB, STa, and STb.","date":"2010","source":"Applied microbiology and biotechnology","url":"https://pubmed.ncbi.nlm.nih.gov/21085949","citation_count":22,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"27942840","id":"PMC_27942840","title":"Expression of an immunogenic LTB-based chimeric protein targeting Zaire ebolavirus epitopes from GP1 in plant cells.","date":"2016","source":"Plant cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/27942840","citation_count":20,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"27382020","id":"PMC_27382020","title":"A Nonoligomerizing Mutant Form of Helicobacter pylori VacA Allows Structural Analysis of the p33 Domain.","date":"2016","source":"Infection and immunity","url":"https://pubmed.ncbi.nlm.nih.gov/27382020","citation_count":20,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"22282702","id":"PMC_22282702","title":"Structure-function studies using deletion mutants identify domains of gC1qR/p33 as potential therapeutic targets for vascular permeability and inflammation.","date":"2011","source":"Frontiers in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/22282702","citation_count":20,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"11835353","id":"PMC_11835353","title":"Expression and sequence analyses of p33(ING1) gene in myeloid leukemia.","date":"2002","source":"American journal of hematology","url":"https://pubmed.ncbi.nlm.nih.gov/11835353","citation_count":19,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"28053185","id":"PMC_28053185","title":"Macrophage LTB4 drives efficient phagocytosis of Borrelia burgdorferi via BLT1 or BLT2.","date":"2017","source":"Journal of lipid research","url":"https://pubmed.ncbi.nlm.nih.gov/28053185","citation_count":18,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"16145550","id":"PMC_16145550","title":"Expression of Escherichia coli heat-labile enterotoxin B subunit (LTB) in Saccharomyces cerevisiae.","date":"2005","source":"Journal of microbiology (Seoul, Korea)","url":"https://pubmed.ncbi.nlm.nih.gov/16145550","citation_count":18,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"22843747","id":"PMC_22843747","title":"TAK1 contributes to the enhanced responsiveness of LTB(4)-treated neutrophils to Toll-like receptor ligands.","date":"2012","source":"International immunology","url":"https://pubmed.ncbi.nlm.nih.gov/22843747","citation_count":18,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"24942226","id":"PMC_24942226","title":"Treatment with p33 curtails morbidity and mortality in a histone-induced murine shock model.","date":"2014","source":"Journal of innate immunity","url":"https://pubmed.ncbi.nlm.nih.gov/24942226","citation_count":18,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"17892212","id":"PMC_17892212","title":"The exosporium of B. cereus contains a binding site for gC1qR/p33: implication in spore attachment and/or entry.","date":"2007","source":"Advances in experimental medicine and biology","url":"https://pubmed.ncbi.nlm.nih.gov/17892212","citation_count":18,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"25266629","id":"PMC_25266629","title":"T lymphocytes maintain structure and function of fibroblastic reticular cells via lymphotoxin (LT)-B.","date":"2014","source":"BMC immunology","url":"https://pubmed.ncbi.nlm.nih.gov/25266629","citation_count":18,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"35201443","id":"PMC_35201443","title":"New immunological potential markers for triple negative breast cancer: IL18R1, CD53, TRIM, Jaw1, LTB, PTPRCAP.","date":"2021","source":"Discover oncology","url":"https://pubmed.ncbi.nlm.nih.gov/35201443","citation_count":18,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"21318355","id":"PMC_21318355","title":"Immunogenicity of nuclear-encoded LTB:ST fusion protein from Escherichia coli expressed in tobacco plants.","date":"2011","source":"Plant cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/21318355","citation_count":17,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"27832917","id":"PMC_27832917","title":"Immune response characterization and vaccine potential of a recombinant chimera comprising B-cell epitope of Aeromonas hydrophila outer membrane protein C and LTB.","date":"2016","source":"Vaccine","url":"https://pubmed.ncbi.nlm.nih.gov/27832917","citation_count":17,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"31234498","id":"PMC_31234498","title":"Effects of the Pentapeptide P33 on Memory and Synaptic Plasticity in APP/PS1 Transgenic Mice: A Novel Mechanism Presenting the Protein Fe65 as a Target.","date":"2019","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/31234498","citation_count":17,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"11606320","id":"PMC_11606320","title":"Pharmacological comparison of LTB(4)-induced NADPH oxidase activation in adherent and non-adherent guinea-pig eosinophils.","date":"2001","source":"British journal of pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/11606320","citation_count":17,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"29894720","id":"PMC_29894720","title":"LTB4 and PGE2 modulate the release of MIP-1α and IL-1β by cells stimulated with Bothrops snake venoms.","date":"2018","source":"Toxicon : official journal of the International Society on Toxinology","url":"https://pubmed.ncbi.nlm.nih.gov/29894720","citation_count":16,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"26724200","id":"PMC_26724200","title":"Recombinant baculovirus vaccine containing multiple M2e and adjuvant LTB induces T cell dependent, cross-clade protection against H5N1 influenza virus in mice.","date":"2015","source":"Vaccine","url":"https://pubmed.ncbi.nlm.nih.gov/26724200","citation_count":16,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"19462253","id":"PMC_19462253","title":"Enhancement of mucosal immune response against the M2eHBc+ antigen in mice with the fusion expression products of LTB and M2eHBc+ through mucosal immunization route.","date":"2009","source":"Veterinary research communications","url":"https://pubmed.ncbi.nlm.nih.gov/19462253","citation_count":15,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"24174616","id":"PMC_24174616","title":"p33 (gC1q receptor) prevents cell damage by blocking the cytolytic activity of antimicrobial peptides.","date":"2013","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/24174616","citation_count":15,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"15534913","id":"PMC_15534913","title":"Genetic alterations and reduced expression of tumor suppressor p33(ING1b) in human exocrine pancreatic carcinoma.","date":"2004","source":"World journal of gastroenterology","url":"https://pubmed.ncbi.nlm.nih.gov/15534913","citation_count":15,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"32141354","id":"PMC_32141354","title":"A Non-Conserved p33 Protein of Citrus Tristeza Virus Interacts with Multiple Viral Partners.","date":"2020","source":"Molecular plant-microbe interactions : MPMI","url":"https://pubmed.ncbi.nlm.nih.gov/32141354","citation_count":15,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"17805569","id":"PMC_17805569","title":"Nuclear to cytoplasmic shift of p33(ING1b) protein from normal oral mucosa to oral squamous cell carcinoma in relation to clinicopathological variables.","date":"2007","source":"Journal of cancer research and clinical oncology","url":"https://pubmed.ncbi.nlm.nih.gov/17805569","citation_count":15,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"21102463","id":"PMC_21102463","title":"Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci.","date":"2010","source":"Nature genetics","url":"https://pubmed.ncbi.nlm.nih.gov/21102463","citation_count":2036,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"12477932","id":"PMC_12477932","title":"Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences.","date":"2002","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/12477932","citation_count":1479,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"21873635","id":"PMC_21873635","title":"Phylogenetic-based propagation of functional annotations within the Gene Ontology consortium.","date":"2011","source":"Briefings in bioinformatics","url":"https://pubmed.ncbi.nlm.nih.gov/21873635","citation_count":656,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"1670638","id":"PMC_1670638","title":"Polymorphic structure of the tumor necrosis factor (TNF) locus: an NcoI polymorphism in the first intron of the human TNF-beta gene correlates with a variant amino acid in position 26 and a reduced level of TNF-beta production.","date":"1991","source":"The Journal of experimental medicine","url":"https://pubmed.ncbi.nlm.nih.gov/1670638","citation_count":506,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"2995927","id":"PMC_2995927","title":"Human lymphotoxin and tumor necrosis factor genes: structure, homology and chromosomal localization.","date":"1985","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/2995927","citation_count":506,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"7916655","id":"PMC_7916655","title":"Lymphotoxin beta, a novel member of the TNF family that forms a heteromeric complex with lymphotoxin on the cell surface.","date":"1993","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/7916655","citation_count":444,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"15489334","id":"PMC_15489334","title":"The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).","date":"2004","source":"Genome research","url":"https://pubmed.ncbi.nlm.nih.gov/15489334","citation_count":438,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"19800575","id":"PMC_19800575","title":"A lymphotoxin-driven pathway to hepatocellular carcinoma.","date":"2009","source":"Cancer cell","url":"https://pubmed.ncbi.nlm.nih.gov/19800575","citation_count":329,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"10318773","id":"PMC_10318773","title":"A newly identified member of tumor necrosis factor receptor superfamily (TR6) suppresses LIGHT-mediated apoptosis.","date":"1999","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/10318773","citation_count":304,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"19115949","id":"PMC_19115949","title":"Genomewide association study of an AIDS-nonprogression cohort emphasizes the role played by HLA genes (ANRS Genomewide Association Study 02).","date":"2009","source":"The Journal of infectious diseases","url":"https://pubmed.ncbi.nlm.nih.gov/19115949","citation_count":193,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"19913121","id":"PMC_19913121","title":"Gene-centric association signals for lipids and apolipoproteins identified via the HumanCVD BeadChip.","date":"2009","source":"American journal of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/19913121","citation_count":164,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"7995952","id":"PMC_7995952","title":"Characterization of surface lymphotoxin forms. Use of specific monoclonal antibodies and soluble receptors.","date":"1995","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/7995952","citation_count":138,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"9317127","id":"PMC_9317127","title":"Characterization of lymphotoxin-alpha beta complexes on the surface of mouse lymphocytes.","date":"1997","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/9317127","citation_count":129,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"8499947","id":"PMC_8499947","title":"Dense Alu clustering and a potential new member of the NF kappa B family within a 90 kilobase HLA class III segment.","date":"1993","source":"Nature genetics","url":"https://pubmed.ncbi.nlm.nih.gov/8499947","citation_count":118,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"23524463","id":"PMC_23524463","title":"Lymphotoxin signalling in immune homeostasis and the control of microorganisms.","date":"2013","source":"Nature reviews. Immunology","url":"https://pubmed.ncbi.nlm.nih.gov/23524463","citation_count":113,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"19851445","id":"PMC_19851445","title":"High-density SNP screening of the major histocompatibility complex in systemic lupus erythematosus demonstrates strong evidence for independent susceptibility regions.","date":"2009","source":"PLoS genetics","url":"https://pubmed.ncbi.nlm.nih.gov/19851445","citation_count":109,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"8629302","id":"PMC_8629302","title":"Allograft inflammatory factory-1. A cytokine-responsive macrophage molecule expressed in transplanted human hearts.","date":"1996","source":"Transplantation","url":"https://pubmed.ncbi.nlm.nih.gov/8629302","citation_count":108,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"11823516","id":"PMC_11823516","title":"Innate direct anticancer effector function of human immature dendritic cells. II. Role of TNF, lymphotoxin-alpha(1)beta(2), Fas ligand, and TNF-related apoptosis-inducing ligand.","date":"2002","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/11823516","citation_count":107,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"9545284","id":"PMC_9545284","title":"Role of transcriptional repressor ICER in cyclic AMP-mediated attenuation of cytokine gene expression in human thymocytes.","date":"1998","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/9545284","citation_count":98,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"19222863","id":"PMC_19222863","title":"Blockade of lymphotoxin-beta receptor signaling reduces aspects of Sjögren's syndrome in salivary glands of non-obese diabetic mice.","date":"2009","source":"Arthritis research & therapy","url":"https://pubmed.ncbi.nlm.nih.gov/19222863","citation_count":95,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"16702430","id":"PMC_16702430","title":"Rapid evolution of major histocompatibility complex class I genes in primates generates new disease alleles in humans via hitchhiking diversity.","date":"2006","source":"Genetics","url":"https://pubmed.ncbi.nlm.nih.gov/16702430","citation_count":84,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"1714477","id":"PMC_1714477","title":"Lymphotoxin and an associated 33-kDa glycoprotein are expressed on the surface of an activated human T cell hybridoma.","date":"1991","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/1714477","citation_count":80,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"15077289","id":"PMC_15077289","title":"Association of the major histocompatibility complex with response to infliximab therapy in rheumatoid arthritis patients.","date":"2004","source":"Arthritis and rheumatism","url":"https://pubmed.ncbi.nlm.nih.gov/15077289","citation_count":79,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"14656967","id":"PMC_14656967","title":"Analysis of the gene-dense major histocompatibility complex class III region and its comparison to mouse.","date":"2003","source":"Genome research","url":"https://pubmed.ncbi.nlm.nih.gov/14656967","citation_count":74,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"17981284","id":"PMC_17981284","title":"Variation in inflammation-related genes and risk of incident nonfatal myocardial infarction or ischemic stroke.","date":"2007","source":"Atherosclerosis","url":"https://pubmed.ncbi.nlm.nih.gov/17981284","citation_count":74,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"18292573","id":"PMC_18292573","title":"Lymphotoxin-alpha 1 beta 2 and LIGHT induce classical and noncanonical NF-kappa B-dependent proinflammatory gene expression in vascular endothelial cells.","date":"2008","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/18292573","citation_count":74,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"9480751","id":"PMC_9480751","title":"Nucleotide sequencing analysis of the 146-kilobase segment around the IkBL and MICA genes at the centromeric end of the HLA class I region.","date":"1998","source":"Genomics","url":"https://pubmed.ncbi.nlm.nih.gov/9480751","citation_count":71,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"8081366","id":"PMC_8081366","title":"Characterization of a novel gene in the human major histocompatibility complex that encodes a potential new member of the I kappa B family of proteins.","date":"1994","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/8081366","citation_count":66,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"20662065","id":"PMC_20662065","title":"Identification of candidate loci at 6p21 and 21q22 in a genome-wide association study of cardiac manifestations of neonatal lupus.","date":"2010","source":"Arthritis and rheumatism","url":"https://pubmed.ncbi.nlm.nih.gov/20662065","citation_count":61,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"10202016","id":"PMC_10202016","title":"A new member of the Ig superfamily and a V-ATPase G subunit are among the predicted products of novel genes close to the TNF locus in the human MHC.","date":"1999","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/10202016","citation_count":60,"is_preprint":false,"source_track":"gene2pubmed"}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":50408,"output_tokens":3412,"usd":0.101202},"stage2":{"model":"claude-opus-4-6","input_tokens":6816,"output_tokens":2894,"usd":0.159645},"total_usd":0.527177,"stage1_batch_id":"msgbatch_01Mgbec4vM6c9vXht7JVJzss","stage2_batch_id":"msgbatch_01JkuuH5RB2BdJNsgnhjbC6s","note":"batch pricing = 50% of standard","round2_stage1":{"model":"claude-sonnet-4-6","input_tokens":65448,"output_tokens":3111,"usd":0.121505},"round2_rules_fired":"R3","round2_stage2":{"model":"claude-opus-4-6","input_tokens":6500,"output_tokens":2562,"usd":0.144825}},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2017,\n      \"finding\": \"LTB4 signals through two receptors: high-affinity BLT1 expressed on leukocytes mediating inflammatory cell recruitment and pathogen elimination, and low-affinity BLT2 expressed on epithelial cells; BLT2 was later found to have 12-HHT as its high-affinity endogenous ligand and mediates skin wound healing by enhancing keratinocyte migration and cell-cell junctions.\",\n      \"method\": \"BLT1-deficient mouse analysis, receptor pharmacology, cell migration assays\",\n      \"journal\": \"Seminars in immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — replicated across multiple labs with genetic KO models and pharmacological assays\",\n      \"pmids\": [\"29042026\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"LTA4 hydrolase (LTA4H) converts LTA4 to LTB4 via an epoxide hydrolase mechanism involving Zn2+, Y383, E271, D375, and two catalytic waters; crystal structures of LTA4H complexed with LTA4 revealed dynamic domain movements that open the active site for substrate entry.\",\n      \"method\": \"High-resolution X-ray crystallography, structural analysis of enzyme-substrate complex\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — crystal structure of enzyme-substrate complex with catalytic residue identification\",\n      \"pmids\": [\"28827365\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"LTB4 drives a complement-lipid-cytokine-chemokine cascade that initiates and sustains neutrophilic inflammation in inflammatory arthritis via BLT1.\",\n      \"method\": \"Animal models of inflammatory arthritis, genetic and pharmacological inhibition of LTB4/BLT1 pathway\",\n      \"journal\": \"Seminars in immunology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — multiple animal model studies but primarily review of mechanistic cascade\",\n      \"pmids\": [\"29042029\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"LTB4 causes nasal gland serous cell secretion via neutrophil recruitment and subsequent neutrophil elastase release; selective inhibition of neutrophil elastase prevented LTB4-induced nasal secretion and lysozyme secretion without affecting neutrophil recruitment.\",\n      \"method\": \"In vivo nasal segment superfusion model in dogs, selective elastase inhibitor ICI 200,355\",\n      \"journal\": \"American journal of respiratory and critical care medicine\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — direct in vivo mechanistic dissection with pharmacological inhibitor showing pathway placement\",\n      \"pmids\": [\"10430706\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"LTB4 at subnanomolar concentrations induces rapid, transient LFA-1-dependent adhesion of neutrophils to ICAM-1 with distinct kinetics and topography compared to Mac-1, with LFA-1-bound material remaining at lamellipodia while Mac-1-bound material translocates to the uropod.\",\n      \"method\": \"Integrin adhesion kinetics assay using ICAM-1-coated beads, monoclonal antibody blocking, flow cytometry\",\n      \"journal\": \"American journal of physiology. Cell physiology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — direct mechanistic dissection with multiple antibody and kinetic measurements\",\n      \"pmids\": [\"11600420\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"In immunized mice, antigen challenge triggers a mediator cascade for neutrophil recruitment: MIP-2 (via CXCR2) induces sequential release of MIP-1alpha, which triggers TNF-alpha release, which in turn triggers LTB4 production; LTB4 is the final effector of neutrophil influx.\",\n      \"method\": \"Genetic epistasis using antibody neutralization and pharmacological inhibition (MK886) in immunized mouse model\",\n      \"journal\": \"European journal of immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal inhibition approaches (antibody + pharmacological) defining cascade order\",\n      \"pmids\": [\"16856209\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"PGE2, LTB4, and PAF regulate cytokine gene expression; LTB4 modulates cytokine production in phagocytes through lipid mediator-cytokine crosstalk pathways.\",\n      \"method\": \"Cytokine gene regulation assays\",\n      \"journal\": \"Mediators of inflammation\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 — review-type finding with limited primary mechanistic data cited\",\n      \"pmids\": [\"18475433\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"15(S)-HETE inhibits 5-lipoxygenase metabolite production, thereby reducing LTB4 levels and modulating neutrophil chemotaxis in chronic bronchitis airways.\",\n      \"method\": \"HPLC quantification of eicosanoids in induced sputum, in vitro inhibition assay of LTB4 production\",\n      \"journal\": \"American journal of physiology. Cell physiology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — direct in vitro and ex vivo mechanistic link between 15-HETE and LTB4 production inhibition\",\n      \"pmids\": [\"11003605\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"Several NSAIDs (diclofenac, indomethacin, niflumic acid) potently inhibit PG-LXR/LTB4 dehydrogenase (the enzyme that metabolizes LTB4), making them dual COX/eicosanoid oxidoreductase inhibitors; 15-PGDH was not significantly inhibited by these NSAIDs.\",\n      \"method\": \"In vitro enzyme inhibition assay using recombinant 15-PGDH and PG-LXR/LTB4DH\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vitro enzymatic assay with recombinant enzymes demonstrating direct inhibition\",\n      \"pmids\": [\"11688989\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"20-OH-LTB4 and 20-COOH-LTB4, LTB4 metabolites generated by neutrophil omega-oxidation, act as natural competitive inhibitors of BLT1-mediated neutrophil and eosinophil responses (migration, degranulation, leukotriene biosynthesis), without affecting fMLP- or IL-8-mediated responses.\",\n      \"method\": \"Human neutrophil and eosinophil functional assays (migration, degranulation, leukotriene biosynthesis) with pharmacological comparison to BLT1 antagonist CP 105,696\",\n      \"journal\": \"Journal of leukocyte biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal functional assays with pharmacological controls demonstrating receptor-specific inhibition\",\n      \"pmids\": [\"30676680\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"LTB4 potentiates TLR-ligand-induced cytokine secretion in human neutrophils through TAK1 and p38 kinase phosphorylation; IRAK is dispensable for this priming effect, and TAK1 or p38 inhibition abolishes LTB4-mediated TLR response enhancement.\",\n      \"method\": \"Pharmacological inhibition of signaling kinases, siRNA knockdown of TAK1, cytokine secretion assay, phosphorylation analysis\",\n      \"journal\": \"International immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple inhibitors plus siRNA knockdown identifying specific signaling pathway mediating LTB4 priming\",\n      \"pmids\": [\"22843747\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"LTB4 promotes macrophage phagocytosis of Borrelia burgdorferi via the high-affinity receptor BLT1; BLT2 can compensate for BLT1 absence but is not the primary receptor; BLT2-specific ligand 12-HHT and BLT1 agonist resolvin E1 could not substitute for LTB4 in promoting phagocytosis.\",\n      \"method\": \"Bone marrow-derived macrophages from 5-LOX-/-, BLT1-/-, and BLT2-/- mice; BLT2 antagonist LY255283; phagocytosis and bacterial killing assays\",\n      \"journal\": \"Journal of lipid research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple genetic KO models with pharmacological validation demonstrating receptor specificity\",\n      \"pmids\": [\"28053185\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"Novel LTA4H modulators were developed that selectively inhibit LTB4 generation while leaving the aminopeptidase activity (PGP degradation) of LTA4H intact, demonstrating that the two enzymatic activities of LTA4H can be pharmacologically dissociated.\",\n      \"method\": \"Enzyme inhibition assays, mouse in vivo PGP accumulation studies, compound structure-activity relationship analysis\",\n      \"journal\": \"Scientific reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — direct enzymatic assays with in vivo validation demonstrating dual activity dissociation\",\n      \"pmids\": [\"28303931\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"T lymphocytes maintain fibroblastic reticular cell (FRC) structure and function in the spleen via lymphotoxin (LT)-B; absence of T cells downregulated LT-B expression, causing FRC structural disorder and reduced CCL21/CCL19 expression, and blocking the LT-B receptor prevented FRC restoration by T cell transfusion.\",\n      \"method\": \"Nude mouse model, T cell transfusion, LT-B receptor blockade, immunostaining, flow cytometry\",\n      \"journal\": \"BMC immunology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — genetic depletion model with receptor blockade rescue experiment establishing LT-B as mediator\",\n      \"pmids\": [\"25266629\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"In vascular smooth muscle cells, 4-hydroxynonenal (HNE) activates 5-lipoxygenase via p38 MAPK and ERK pathways, leading to nuclear translocation of 5-LO and LTB4 production; LTB4 then signals through BLT (LTB4) receptors (not cysLT receptors) to enhance MMP-2 production.\",\n      \"method\": \"5-LO-deficient VSMCs, FLAP inhibitor MK886, LT receptor antagonists, p38/ERK inhibitors, nuclear translocation imaging\",\n      \"journal\": \"Atherosclerosis\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — multiple pharmacological and genetic approaches establishing signaling pathway from HNE to LTB4 to MMP-2\",\n      \"pmids\": [\"19586628\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"LTB4 (leukotriene B4) is a lipid mediator biosynthesized from arachidonic acid by the enzyme LTA4 hydrolase (via an epoxide hydrolase mechanism involving Zn2+, catalytic waters, and key residues Y383/E271/D375) that acts on two GPCRs — high-affinity BLT1 on leukocytes and low-affinity BLT2 on epithelial cells — to drive neutrophil and eosinophil recruitment, phagocytosis, integrin activation, TLR priming (via TAK1/p38), and cytokine cascades in inflammation, while omega-oxidized metabolites 20-OH-LTB4 and 20-COOH-LTB4 act as natural BLT1 competitive inhibitors to limit these responses; in lymphoid tissue, membrane-bound lymphotoxin-B (LTB) on T lymphocytes signals to fibroblastic reticular cells to maintain their structural integrity and chemokine expression via the LTB receptor.\"\n}\n```\n\n--- ROUND 2 (R2/R3, augmented corpus) ---\n\nLooking at the corpus, I need to identify papers about the canonical human LTB gene (Lymphotoxin Beta, a TNF superfamily member that forms heteromeric complexes with LTα on cell surfaces and signals through LTβR).\n\n**Classification:**\n- Papers about LTB (Lymphotoxin Beta, TNF superfamily): KEEP — papers [6 from curated list: PMID 7916655, 7995952, 9317127, 11823516, 9545284, 18292573, 19800575, 19462253 (curated #18,12,13,18,19,26,8,... let me re-check)]\n- Papers about p33/ING1, gC1qR/p33, tombusvirus p33, VacA p33, LTB4 (leukotriene B4), LTB (enterotoxin B subunit), baculovirus p33, etc.: EXCLUDE — alias collisions\n\nFrom the **retrieved papers** (100): Nearly all are about p33 variants (ING1, gC1qR, tombusvirus, VacA, baculovirus), LTB4 (leukotriene B4), or LTB as E. coli enterotoxin B subunit. Paper [88] (PMID:25266629) mentions LT-B in context of fibroblastic reticular cells — this uses \"LT-B\" to mean Lymphotoxin Beta. Paper [89] (PMID:35201443) mentions LTB as a gene — but it's primarily a biomarker/expression study, no mechanism.\n\nFrom the **curated papers**: PMID 7916655, 7995952, 9317127, 11823516, 9545284, 18292573, 19800575, 25266629 are relevant to LTB mechanistic findings.\n\n```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1993,\n      \"finding\": \"LTB (lymphotoxin beta) was identified as a novel type II transmembrane protein of the TNF superfamily that forms a heteromeric complex with LTα (lymphotoxin alpha) on the cell surface of activated T, B, and LAK cells. The LTα/LTβ complex is anchored to the membrane via LTβ, and the LTB gene was found adjacent to the TNF-LTα locus within the MHC.\",\n      \"method\": \"cDNA cloning, immunoprecipitation, surface immunofluorescence, Northern blot, chromosomal mapping\",\n      \"journal\": \"Cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — original discovery paper with cDNA cloning, co-IP/immunoprecipitation demonstrating complex formation, and multiple orthogonal characterization methods; foundational paper with 444 citations\",\n      \"pmids\": [\"7916655\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1991,\n      \"finding\": \"Surface lymphotoxin on activated T cell hybridoma II-23.D7 exists as a complex between LTα (p25) and an associated 33 kDa glycoprotein (later identified as LTβ). Peptide mapping showed p33 is biochemically distinct from LTα, and biosynthetic labeling showed p33 contains cysteine whereas p25/LTα does not, indicating p33 anchors LTα to the cell surface.\",\n      \"method\": \"Surface radioiodination, immunoprecipitation with anti-LT antibodies, CNBr peptide mapping, biosynthetic labeling, glycanase digestion\",\n      \"journal\": \"Journal of immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — multiple biochemical methods (immunoprecipitation, peptide mapping, biosynthetic labeling) establishing the identity and membrane-anchoring role of LTβ; 80 citations\",\n      \"pmids\": [\"1714477\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1995,\n      \"finding\": \"Two distinct surface LT complexes were characterized on PMA-activated T cells: a minor LTα2/β1 form recognized by the p55-TNF receptor, and a predominant LTα1/β2 form that is the primary ligand for the LTβ receptor. Neither heteromeric form is secreted. The LTα1/β2 stoichiometry was confirmed using panels of anti-LTα and anti-LTβ monoclonal antibodies and soluble receptor-Ig fusion proteins.\",\n      \"method\": \"FACS with monoclonal antibodies, soluble receptor-Ig binding assays, immunoprecipitation, flow cytometry\",\n      \"journal\": \"Journal of immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — reciprocal antibody characterization and soluble receptor binding with multiple mAbs establishing stoichiometry of LTα/LTβ surface complexes; replicated across multiple cell lines; 138 citations\",\n      \"pmids\": [\"7995952\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1997,\n      \"finding\": \"In mouse lymphocytes, CD4+ T cells, CD8+ T cells, and B cells express surface LTα/LTβ complexes upon activation, while monocytes/macrophages express LTβ receptor but not surface LT ligand. Murine surface LT complex properties parallel those in humans, establishing conserved expression patterns across species.\",\n      \"method\": \"FACS analysis with anti-murine LTα, LTβ monoclonal antibodies and soluble LTβR-Ig and TNF-R55-Ig fusion proteins on primary splenocytes, thymocytes, lymph node and peritoneal cells\",\n      \"journal\": \"Journal of immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — systematic characterization of primary murine immune cell populations using reciprocal antibody and soluble receptor tools; 129 citations\",\n      \"pmids\": [\"9317127\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"cAMP-mediated transcriptional repressor ICER attenuates lymphotoxin-beta gene expression in human thymocytes by binding to NFAT/AP-1 composite DNA sites in the LTβ promoter region, forming NFAT/ICER ternary complexes that repress transcription.\",\n      \"method\": \"EMSA (electrophoretic mobility shift assay), transient transfection with ICER expression constructs, luciferase reporter assays, Northern blot analysis of primary thymocytes\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — EMSA and reporter assays establishing ICER binding to LTβ promoter elements and functional repression; single lab study\",\n      \"pmids\": [\"9545284\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"Human immature dendritic cells express LTα1β2 on their cell surface as one of four TNF family cytotoxic ligands mediating direct apoptotic killing of tumor cells. Blocking LTα1β2 interactions with LTβR on tumor cells using specific antibodies or LTβR:Fc fusion proteins reduced DC-mediated tumor cell killing.\",\n      \"method\": \"Flow cytometry for surface expression, neutralizing antibodies and receptor:Fc fusion protein blockade, cytotoxicity assays with freshly isolated and cultured cancer cells\",\n      \"journal\": \"Journal of immunology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — functional blocking experiments with defined reagents establishing LTα1β2 as a mediator of DC cytotoxicity; single lab\",\n      \"pmids\": [\"11823516\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"LTα1β2 (as well as LIGHT) activates both classical and noncanonical NF-κB pathways in vascular endothelial cells, inducing expression of adhesion molecules (E-selectin, ICAM-1, VCAM-1) via classical NF-κB and homeostatic chemokine CXCL12 via the noncanonical pathway. CXCL12 induction by LTβR ligation is dependent on IKKα (noncanonical pathway) as shown by dominant-negative IKKα retroviral transduction.\",\n      \"method\": \"NF-κB pathway activation assays, retroviral transduction with dominant-negative IKKα, qRT-PCR and Western blot for target genes, T cell adhesion assays in HUVEC and HDMEC\",\n      \"journal\": \"Journal of immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — mechanistic pathway dissection using dominant-negative constructs, multiple cell types, and multiple orthogonal readouts; 74 citations\",\n      \"pmids\": [\"18292573\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"Hepatic overexpression of LTα and LTβ in transgenic mice induces liver inflammation and hepatocellular carcinoma (HCC). HCC development depends on lymphocytes and hepatocyte-expressed IKKβ (classical NF-κB signaling) but is independent of TNFR1. In vivo LTβR inhibition with LTβR:Ig fusion protein suppressed HCC formation in LTαβ-transgenic mice with hepatitis, establishing LTβR signaling as causally linked to hepatitis-induced HCC.\",\n      \"method\": \"Liver-specific LTαβ transgenic mouse model, LTβR:Ig blockade in vivo, IKKβ conditional knockout, TNFR1-deficient crosses, histopathology, A6+ oval cell staining\",\n      \"journal\": \"Cancer cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic epistasis via multiple knockout/transgenic crosses and in vivo receptor blockade establishing causal LTβ→LTβR→IKKβ pathway in HCC; 329 citations\",\n      \"pmids\": [\"19800575\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"T lymphocyte-derived LTβ maintains the structure and function of fibroblastic reticular cells (FRCs) in the spleen. In nude mice lacking T cells, FRC structure was disrupted, ER-TR7 secretion was reduced, and CCL21/CCL19 expression was downregulated. Transfusion of T cells restored FRC structure and function, but this restoration was abrogated when LTβ receptor was blocked, identifying LTβ as the T cell-derived signal required for FRC homeostasis.\",\n      \"method\": \"Nude mouse model (T cell-deficient), T cell transfer experiments, LTβR blockade, immunohistochemistry for FRC markers, qRT-PCR for CCL19/CCL21, T cell homing assays\",\n      \"journal\": \"BMC immunology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — genetic loss-of-function (nude mice) combined with rescue (T cell transfer) and receptor blockade establishing LTβ as the functional signal; single lab\",\n      \"pmids\": [\"25266629\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"LTB encodes lymphotoxin beta (LTβ), a type II transmembrane TNF superfamily member that anchors LTα to the lymphocyte surface as predominant LTα1β2 heterotrimers (minor LTα2β1 also exists); this surface complex signals exclusively through the LTβ receptor (LTβR) to activate both classical (IKKβ-dependent) and noncanonical (IKKα-dependent) NF-κB pathways, driving lymphoid organogenesis, FRC homeostasis, endothelial activation (ICAM-1, VCAM-1, CXCL12 induction), DC-mediated tumor cytotoxicity, and—when chronically overexpressed in the liver—hepatocellular carcinoma via IKKβ in a TNFR1-independent manner.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"LTB4 is a potent lipid mediator of innate immunity derived from arachidonic acid that orchestrates neutrophil and eosinophil recruitment, integrin-dependent adhesion, phagocytosis, and cytokine amplification at sites of inflammation. LTA4 hydrolase converts LTA4 to LTB4 via a Zn2+-dependent epoxide hydrolase mechanism involving catalytic residues Y383, E271, D375, and two catalytic waters, with crystal structures revealing dynamic domain movements that gate substrate access [PMID:28827365]; the enzyme's LTB4-generating and aminopeptidase activities are pharmacologically separable [PMID:28303931]. LTB4 signals primarily through high-affinity BLT1 on leukocytes to drive neutrophil chemotaxis, LFA-1/Mac-1-mediated adhesion to ICAM-1, macrophage phagocytosis of pathogens, and TAK1/p38-dependent potentiation of TLR-induced cytokine secretion [PMID:29042026, PMID:11600420, PMID:28053185, PMID:22843747]; its omega-oxidized metabolites 20-OH-LTB4 and 20-COOH-LTB4 serve as endogenous competitive BLT1 antagonists that limit these inflammatory responses [PMID:30676680]. In lymphoid tissue, membrane-bound lymphotoxin-β (LTB) expressed by T lymphocytes signals through the LTβ receptor on fibroblastic reticular cells to maintain their structural integrity and CCL21/CCL19 chemokine expression [PMID:25266629].\",\n  \"teleology\": [\n    {\n      \"year\": 2001,\n      \"claim\": \"Early work established that LTB4 functions as a terminal effector of neutrophil recruitment and integrin activation, demonstrating that subnanomolar LTB4 induces rapid LFA-1- and Mac-1-dependent neutrophil adhesion to ICAM-1 with spatially distinct integrin localization, and that LTB4-induced nasal secretion depends on neutrophil elastase downstream of neutrophil recruitment.\",\n      \"evidence\": \"Integrin adhesion kinetics with ICAM-1-coated beads and monoclonal antibody blocking; in vivo canine nasal superfusion with selective elastase inhibitor\",\n      \"pmids\": [\"11600420\", \"10430706\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Intracellular signaling linking BLT1 activation to integrin conformational change was not defined\",\n        \"Whether LFA-1 vs Mac-1 differential localization is receptor-specific or cell-type-specific was unresolved\"\n      ]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Genetic epistasis experiments placed LTB4 as the final effector in a chemokine-cytokine cascade (MIP-2 → MIP-1α → TNF-α → LTB4) driving antigen-triggered neutrophil influx, establishing its hierarchical position downstream of multiple cytokines.\",\n      \"evidence\": \"Sequential antibody neutralization and pharmacological inhibition (MK886) in immunized mouse model\",\n      \"pmids\": [\"16856209\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Whether this cascade order is conserved in human tissues was not tested\",\n        \"The cellular source of LTB4 in this cascade was not definitively identified\"\n      ]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"LTB4 was shown to act in an autocrine/paracrine loop in vascular smooth muscle cells, where oxidative stress (HNE) activates 5-LO via p38 MAPK and ERK to produce LTB4, which then signals through BLT receptors to upregulate MMP-2, linking LTB4 to vascular remodeling.\",\n      \"evidence\": \"5-LO-deficient VSMCs, FLAP inhibitor, LT receptor antagonists, p38/ERK inhibitors, nuclear translocation imaging\",\n      \"pmids\": [\"19586628\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Whether BLT1 or BLT2 mediates MMP-2 induction in VSMCs was not resolved\",\n        \"In vivo relevance to atherosclerotic plaque progression was not demonstrated\"\n      ]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"The mechanism by which LTB4 primes innate immune responses was elucidated: LTB4 potentiates TLR-ligand-induced cytokine secretion in neutrophils through TAK1 and p38 kinase phosphorylation, with IRAK dispensable, defining a specific signaling branch for lipid-TLR crosstalk.\",\n      \"evidence\": \"Pharmacological inhibition of TAK1 and p38, siRNA knockdown of TAK1, cytokine secretion and phosphorylation assays in human neutrophils\",\n      \"pmids\": [\"22843747\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Whether TAK1/p38 priming applies to all TLR ligands or is receptor-selective was not fully explored\",\n        \"Transcriptional vs. post-translational mechanisms of cytokine enhancement were not distinguished\"\n      ]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Membrane-bound lymphotoxin-β (LTB) was identified as the T cell-derived signal maintaining fibroblastic reticular cell (FRC) architecture and chemokine expression (CCL21/CCL19) in secondary lymphoid organs, establishing a non-lipid LTB function in lymphoid tissue homeostasis.\",\n      \"evidence\": \"Nude mouse model with T cell transfusion, LTβ receptor blockade, immunostaining and flow cytometry in spleen\",\n      \"pmids\": [\"25266629\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Whether LTβ acts directly on FRCs or requires intermediate cell types was not fully resolved\",\n        \"Downstream signaling pathways in FRCs (NF-κB canonical vs non-canonical) were not characterized\"\n      ]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Structural determination of the LTA4H–LTA4 complex revealed the catalytic mechanism of LTB4 biosynthesis (Zn2+, Y383, E271, D375, two catalytic waters, dynamic domain opening), and separate pharmacological studies showed the enzyme's epoxide hydrolase and aminopeptidase activities can be independently modulated.\",\n      \"evidence\": \"High-resolution X-ray crystallography of LTA4H–LTA4 complex; selective enzyme inhibition assays with in vivo PGP accumulation studies\",\n      \"pmids\": [\"28827365\", \"28303931\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Transition-state intermediates were not directly captured crystallographically\",\n        \"Whether selective epoxide hydrolase inhibitors are therapeutically superior to dual-activity inhibitors in vivo remains untested\"\n      ]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Receptor-specific functions of LTB4 were clarified: BLT1 is the primary receptor for macrophage phagocytosis of Borrelia burgdorferi with BLT2 providing partial compensation, while BLT2's high-affinity endogenous ligand was identified as 12-HHT mediating epithelial wound healing rather than classical inflammation.\",\n      \"evidence\": \"Bone marrow-derived macrophages from 5-LOX−/−, BLT1−/−, and BLT2−/− mice with phagocytosis assays; BLT1-deficient mouse analysis and receptor pharmacology\",\n      \"pmids\": [\"28053185\", \"29042026\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Structural basis for BLT1 vs BLT2 ligand selectivity was not determined\",\n        \"Whether BLT2 compensatory phagocytosis is physiologically relevant or an artifact of BLT1 absence is unclear\"\n      ]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Omega-oxidized LTB4 metabolites (20-OH-LTB4, 20-COOH-LTB4) were established as endogenous negative regulators that competitively antagonize BLT1, selectively blocking LTB4-driven neutrophil and eosinophil migration, degranulation, and leukotriene biosynthesis without affecting fMLP or IL-8 responses.\",\n      \"evidence\": \"Human neutrophil and eosinophil functional assays with comparison to BLT1 antagonist CP 105,696\",\n      \"pmids\": [\"30676680\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"In vivo concentrations of omega-oxidized metabolites at inflammatory sites and their actual impact on resolution kinetics are unknown\",\n        \"Whether 20-OH-LTB4 and 20-COOH-LTB4 have any BLT2 activity was not addressed\"\n      ]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"Major open questions include the structural basis for BLT1/BLT2 ligand discrimination, the in vivo dynamics of omega-oxidized LTB4 metabolites in inflammation resolution, the downstream NF-κB signaling of membrane-bound LTβ in fibroblastic reticular cells, and whether selective LTA4H epoxide hydrolase inhibitors offer therapeutic advantages over pan-inhibitors.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\n        \"No cryo-EM or crystal structure of LTB4–BLT1 complex exists\",\n        \"Spatiotemporal dynamics of LTB4 vs omega-oxidized metabolite production in vivo are unmapped\",\n        \"The LTβ receptor signaling axis in FRCs lacks detailed molecular characterization\"\n      ]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0048018\", \"supporting_discovery_ids\": [0, 2, 9, 11]},\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [9]},\n      {\"term_id\": \"GO:0060089\", \"supporting_discovery_ids\": [0, 10, 14]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005576\", \"supporting_discovery_ids\": [0, 5, 9]},\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [13]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-168256\", \"supporting_discovery_ids\": [0, 2, 5, 10, 11]},\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [0, 10, 14]},\n      {\"term_id\": \"R-HSA-1430728\", \"supporting_discovery_ids\": [1, 7, 8, 12]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\n      \"LTB4R\",\n      \"LTB4R2\",\n      \"LTA4H\",\n      \"LTBR\",\n      \"TAK1\",\n      \"ICAM1\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```\n\n--- ROUND 2 (R2/R3, augmented corpus) ---\n\n```json\n{\n  \"mechanistic_narrative\": \"Lymphotoxin-beta (LTβ) is a type II transmembrane TNF superfamily member that anchors lymphotoxin-alpha (LTα) to the lymphocyte surface, forming predominant LTα1β2 heterotrimers that signal exclusively through the LTβ receptor (LTβR) to activate both classical (IKKβ-dependent) and noncanonical (IKKα-dependent) NF-κB pathways [PMID:7916655, PMID:7995952, PMID:18292573]. Surface LTα1β2 is expressed on activated CD4+ T cells, CD8+ T cells, and B cells, as well as immature dendritic cells, where it mediates endothelial activation (ICAM-1, VCAM-1, CXCL12 induction), fibroblastic reticular cell homeostasis, DC-mediated tumor cytotoxicity, and lymphoid tissue organization [PMID:9317127, PMID:11823516, PMID:25266629]. Chronic hepatic overexpression of LTαβ drives inflammation-associated hepatocellular carcinoma through LTβR and IKKβ in a TNFR1-independent manner [PMID:19800575].\",\n  \"teleology\": [\n    {\n      \"year\": 1991,\n      \"claim\": \"The discovery that surface lymphotoxin exists as a complex of LTα with a biochemically distinct 33 kDa glycoprotein (later identified as LTβ) resolved how soluble LTα is retained at the cell membrane.\",\n      \"evidence\": \"Surface radioiodination, immunoprecipitation, CNBr peptide mapping, and biosynthetic labeling on activated T cell hybridoma II-23.D7\",\n      \"pmids\": [\"1714477\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Identity of p33 was not yet established at the molecular/cDNA level\", \"Receptor specificity of the surface complex was unknown\"]\n    },\n    {\n      \"year\": 1993,\n      \"claim\": \"Cloning of the LTB cDNA established LTβ as a type II transmembrane TNF family member encoded within the MHC locus, anchoring LTα to the cell surface of activated T, B, and LAK cells.\",\n      \"evidence\": \"cDNA cloning, co-immunoprecipitation, surface immunofluorescence, Northern blot, and chromosomal mapping\",\n      \"pmids\": [\"7916655\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Stoichiometry of the LTα/LTβ complex was not defined\", \"Which receptor the surface complex engages was unresolved\"]\n    },\n    {\n      \"year\": 1995,\n      \"claim\": \"Defining the stoichiometry of the two surface LT heterotrimers—predominant LTα1β2 and minor LTα2β1—and showing LTα1β2 is the primary LTβR ligand resolved the ligand–receptor specificity question.\",\n      \"evidence\": \"FACS with panels of anti-LTα and anti-LTβ monoclonal antibodies, soluble TNF-R55-Ig and LTβR-Ig binding assays across multiple cell lines\",\n      \"pmids\": [\"7995952\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Downstream signaling pathways triggered by LTβR were not yet dissected\", \"In vivo physiological role of the LTα1β2–LTβR axis was undemonstrated\"]\n    },\n    {\n      \"year\": 1997,\n      \"claim\": \"Demonstration that murine CD4+ T, CD8+ T, and B cells express surface LTα/LTβ upon activation—paralleling the human system—established evolutionary conservation and validated the mouse as a model for LTβ biology.\",\n      \"evidence\": \"FACS analysis of primary murine splenocytes, thymocytes, lymph node and peritoneal cells with anti-murine LTα/LTβ mAbs and soluble receptor-Ig fusions\",\n      \"pmids\": [\"9317127\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Functional consequences of LTβR engagement in vivo (e.g., lymphoid organogenesis) were being established by parallel genetic studies not captured here\"]\n    },\n    {\n      \"year\": 1998,\n      \"claim\": \"Identification of ICER-mediated repression of LTβ transcription via NFAT/AP-1 composite elements revealed a cAMP-dependent brake on LTβ expression in thymocytes.\",\n      \"evidence\": \"EMSA, transient transfection with ICER constructs, luciferase reporter assays, and Northern blot in human thymocytes\",\n      \"pmids\": [\"9545284\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Physiological relevance of ICER repression in peripheral lymphocytes was not tested\", \"Other transcription factors regulating LTβ expression were not identified\"]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"Showing that immature dendritic cells use surface LTα1β2–LTβR interactions to kill tumor cells expanded LTβ's functional repertoire beyond lymphoid organogenesis to innate anti-tumor cytotoxicity.\",\n      \"evidence\": \"Flow cytometry for surface LTα1β2, neutralizing antibodies/LTβR:Fc blockade, and cytotoxicity assays against freshly isolated cancer cells\",\n      \"pmids\": [\"11823516\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Whether DC-expressed LTα1β2 is relevant for tumor control in vivo was not established\", \"The apoptotic pathway downstream of LTβR in tumor cells was not dissected\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Dissection of dual NF-κB pathway activation downstream of LTβR in endothelial cells—classical NF-κB inducing adhesion molecules and noncanonical IKKα-dependent pathway inducing CXCL12—provided a mechanistic framework for LTβ-driven vascular inflammation and immune cell recruitment.\",\n      \"evidence\": \"Dominant-negative IKKα retroviral transduction, qRT-PCR, Western blot, and T cell adhesion assays in HUVEC and HDMEC\",\n      \"pmids\": [\"18292573\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Relative contribution of each NF-κB branch in different tissue contexts was not compared\", \"Whether endothelial CXCL12 induction occurs in vivo during chronic inflammation was not shown\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Genetic epistasis in hepatic LTαβ transgenic mice demonstrated that chronic LTβR signaling drives hepatocellular carcinoma via IKKβ (classical NF-κB) independent of TNFR1, establishing LTβR as a causal oncogenic pathway in inflammation-associated liver cancer.\",\n      \"evidence\": \"Liver-specific LTαβ transgenic mice, LTβR:Ig blockade in vivo, conditional IKKβ knockout, TNFR1-deficient crosses, histopathology\",\n      \"pmids\": [\"19800575\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether human hepatitis-associated HCC is similarly driven by LTβR signaling was not confirmed\", \"Downstream IKKβ target genes responsible for hepatocyte transformation were not identified\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"T cell transfer and LTβR blockade experiments in nude mice identified LTβ as the T cell-derived signal required for maintaining fibroblastic reticular cell structure and chemokine (CCL19/CCL21) production in the spleen, linking LTβ to stromal homeostasis.\",\n      \"evidence\": \"Nude mouse model, T cell adoptive transfer, LTβR blockade, immunohistochemistry for FRC markers, qRT-PCR\",\n      \"pmids\": [\"25266629\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Whether LTβ acts directly on FRCs or through an intermediate cell type was not resolved\", \"FRC maintenance in lymph nodes versus spleen may differ\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"Outstanding questions include the structural basis of LTα1β2–LTβR engagement, the full transcriptional program downstream of LTβR in different tissue-resident cell types, and whether therapeutic LTβR blockade can safely suppress inflammation-driven carcinogenesis without compromising lymphoid tissue integrity.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"High\",\n      \"gaps\": [\"No crystal structure of the LTα1β2–LTβR complex has been reported in the timeline\", \"Comprehensive LTβR target gene programs across cell types remain unmapped\", \"Therapeutic window for LTβR blockade in cancer versus immunodeficiency is undefined\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0048018\", \"supporting_discovery_ids\": [0, 2, 5, 6]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [0, 1, 2, 3, 5]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"GO:0162582\", \"supporting_discovery_ids\": [6, 7]},\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [6, 7]},\n      {\"term_id\": \"R-HSA-168256\", \"supporting_discovery_ids\": [3, 5, 8]},\n      {\"term_id\": \"R-HSA-1643685\", \"supporting_discovery_ids\": [7]}\n    ],\n    \"complexes\": [\n      \"LTα1β2 heterotrimer\",\n      \"LTα2β1 heterotrimer\"\n    ],\n    \"partners\": [\n      \"LTA\",\n      \"LTBR\",\n      \"TNFRSF1A\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}